James E Wooldridge Selected Research

ocaratuzumab

1/2015	Phase 1/2 study of ocaratuzumab, an Fc-engineered humanized anti-CD20 monoclonal antibody, in low-affinity FcγRIIIa patients with previously treated follicular lymphoma.
3/2012	Results of a phase 1 study of AME-133v (LY2469298), an Fc-engineered humanized monoclonal anti-CD20 antibody, in FcγRIIIa-genotyped patients with previously treated follicular lymphoma.
2/2011	Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James E Wooldridge Research Topics

Disease

9	Neoplasms (Cancer) 12/2021 - 11/2003
4	Multiple Myeloma 03/2017 - 07/2011
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2012 - 01/2005
3	Nausea 01/2017 - 09/2006
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2015 - 02/2011
2	Vomiting 01/2017 - 01/2015
2	Fatigue 01/2017 - 03/2012
2	Lymphoma (Lymphomas) 10/2006 - 09/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2006 - 07/2005
1	Melanoma (Melanoma, Malignant) 12/2021
1	Anorexia 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Diarrhea 01/2017
1	Hypocalcemia 01/2017
1	Aspiration Pneumonia 01/2015
1	Septic Shock (Toxic Shock Syndrome) 09/2012
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2012
1	Leukopenia 09/2012
1	Chills 03/2012
1	Myalgia 02/2012
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2011
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2011
1	Anemia 07/2011
1	Thrombocytopenia (Thrombopenia) 07/2011
1	Hyperplasia 01/2007
1	Hypotension (Low Blood Pressure) 09/2006
1	Hodgkin Disease (Hodgkin's Disease) 04/2006
1	Neutropenia 04/2006
1	Febrile Neutropenia 04/2006
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2006

Drug/Important Bio-Agent (IBA)

4	CPG-oligonucleotideIBA 02/2012 - 01/2005
3	Bortezomib (Velcade)FDA Link 03/2017 - 07/2011
3	Pharmaceutical PreparationsIBA 01/2015 - 07/2011
3	ocaratuzumabIBA 01/2015 - 02/2011
3	enzastaurinIBA 09/2014 - 07/2011
3	OligodeoxyribonucleotidesIBA 09/2006 - 01/2005
2	B-Cell Activating FactorIBA 03/2017 - 12/2016
2	tabalumabIBA 03/2017 - 12/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 09/2014 - 09/2012
2	ProMune (CpG 7909)IBA 02/2012 - 09/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2011 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 11/2003
1	Chemokine CXCL10IBA 12/2021
1	pembrolizumabIBA 12/2021
1	Toll-Like Receptor 9IBA 12/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	ArginaseIBA 01/2021
1	Amino Acids FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2017
1	emibetuzumabIBA 01/2017
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 09/2014
1	CaspasesIBA 09/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2014
1	Protein Kinase CIBA 09/2014
1	Rituximab (Mabthera)FDA Link 11/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011
1	Prednisone (Sone)FDA LinkGeneric 11/2011
1	Vincristine (Oncovin)FDA LinkGeneric 11/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2011
1	Valine (L-Valine)FDA Link 02/2011
1	Phenylalanine (L-Phenylalanine)FDA Link 02/2011
1	Immunoglobulin G (IgG)IBA 02/2011
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 01/2007
1	Ephrin-A5 (AL-1)IBA 01/2007
1	interleukin-21 (interleukin 21)IBA 10/2006
1	Granzymes (Granzyme)IBA 10/2006
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2006
1	Dacarbazine (DIC)FDA LinkGeneric 04/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2006
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2005
1	Biological ProductsIBA 01/2005
1	Vaccine AdjuvantsIBA 11/2003
1	OligonucleotidesIBA 11/2003

Therapy/Procedure

5	Therapeutics 12/2021 - 04/2006
3	Immunotherapy 01/2021 - 11/2003
3	Drug Therapy (Chemotherapy) 11/2011 - 02/2006
1	Intravenous Infusions 09/2006
1	Catheters 09/2006
1	Drug Tapering 04/2006